mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.03 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.59 |
0.03 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |